skip to content

Cambridge Cardiovascular

 
Read more at: Dr Benn Jessney

Dr Benn Jessney

Clinical Research Associate / Cardiology Specialty Registrar





Read more at: Dr Tian Zhao

Dr Tian Zhao

Journal articles

2022

  • Zhao, TX., Aetesam-Ur-Rahman, M., Sage, AP., Victor, S., Kurian, R., Fielding, S., Ait-Oufella, H., Chiu, Y-D., Binder, CJ., Mckie, M., Hoole, SP. and Mallat, Z., 2022. Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study. Cardiovasc Res, v. 118
    Doi: http://doi.org/10.1093/cvr/cvab113
  • Zhao, TX., Sriranjan, RS., Tuong, ZK., Lu, Y., Sage, AP., Nus, M., Hubsch, A., Kaloyirou, F., Vamvaka, E., Helmy, J., Kostapanos, M., Jalaludeen, N., Klatzmann, D., Tedgui, A., Rudd, JHF., Horton, SJ., Huntly, BJP., Hoole, SP., Bond, SP., Clatworthy, MR., Cheriyan, J. and Mallat, Z., 2022. Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease. NEJM Evid, v. 1
    Doi: 10.1056/EVIDoa2100009
  • Zhao, TX., Sriranjan, RS., Tuong, ZK., Lu, Y., Sage, AP., Nus, M., Hubsch, A., Kaloyirou, F., Vamvaka, E., Helmy, J., Kostapanos, M., Jalaludeen, N., Klatzmann, D., Tedgui, A., Rudd, JHF., Horton, SJ., Huntly, BJP., Hoole, SP., Bond, SP., Clatworthy, MR., Cheriyan, J. and Mallat, Z., 2022. Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease NEJM Evidence, v. 1
    Doi: 10.1056/evidoa2100009
  • 2021

  • Aetesam-Ur-Rahman, M., Giblett, JP., Khialani, B., Kyranis, S., Clarke, SJ., Zhao, TX., Braganza, DM., Clarke, SC., West, NEJ., Bennett, MR. and Hoole, SP., 2021. GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated. BMC Cardiovasc Disord, v. 21
    Doi: http://doi.org/10.1186/s12872-021-02030-5
  • Yu, X., Newland, SA., Zhao, TX., Lu, Y., Sage, AS., Sun, Y., Sriranjan, RS., Ma, MKL., Lam, BYH., Nus, M., Harrison, JE., Bond, SJ., Cheng, X., Silvestre, J-S., Rudd, JHF., Cheriyan, J. and Mallat, Z., 2021. Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction. J Am Coll Cardiol, v. 78
    Doi: 10.1016/j.jacc.2021.07.018
  • Aetesam-Ur-Rahman, M., Brown, AJ., Jaworski, C., Giblett, JP., Zhao, TX., Braganza, DM., Clarke, SC., Agrawal, BSK., Bennett, MR., West, NEJ. and Hoole, SP., 2021. Adenosine-Induced Coronary Steal Is Observed in Patients Presenting With ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc, v. 10
    Doi: http://doi.org/10.1161/JAHA.120.019899
  • 2020

  • Nus, M., Basatemur, G., Galan, M., Cros-Brunsó, L., Zhao, TX., Masters, L., Harrison, J., Figg, N., Tsiantoulas, D., Geissmann, F., Binder, CJ., Sage, AP. and Mallat, Z., 2020. NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice-Brief Report. Arterioscler Thromb Vasc Biol, v. 40
    Doi: 10.1161/ATVBAHA.120.314607
  • Zhao, TX., Newland, SA. and Mallat, Z., 2020. 2019 ATVB Plenary Lecture: Interleukin-2 Therapy in Cardiovascular Disease: The Potential to Regulate Innate and Adaptive Immunity. Arterioscler Thromb Vasc Biol, v. 40
    Doi: 10.1161/ATVBAHA.119.312287
  • 2019

  • Zhao, TX. and Mallat, Z., 2019. Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review. J Am Coll Cardiol, v. 73
    Doi: http://doi.org/10.1016/j.jacc.2018.12.083
  • Giblett, JP., Clarke, S., Zhao, T., McCormick, LM., Braganza, DM., Densem, CG., O'Sullivan, M., Adlam, D., Clarke, SC., Steele, J., Fielding, S., West, NEJ., Villar, SS. and Hoole, SP., 2019. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial American Heart Journal, v. 215
    Doi: http://doi.org/10.1016/j.ahj.2019.05.013
  • 2018

  • Zhao, TX., Kostapanos, M., Griffiths, C., Arbon, EL., Hubsch, A., Kaloyirou, F., Helmy, J., Hoole, SP., Rudd, JHF., Wood, G., Burling, K., Bond, S., Cheriyan, J. and Mallat, Z., 2018. Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. BMJ Open, v. 8
    Doi: 10.1136/bmjopen-2018-022452
  • Clarke, SJ., Giblett, JP., Yang, LL., Hubsch, A., Zhao, T., Aetesam-Ur-Rahman, M., West, NEJ., O'Sullivan, M., Figg, N., Bennett, M., Wewer Albrechtsen, NJ., Deacon, CF., Cheriyan, J. and Hoole, SP., 2018. GLP-1 Is a Coronary Artery Vasodilator in Humans. J Am Heart Assoc, v. 7
    Doi: 10.1161/JAHA.118.010321
  • 2011

  • Holtzman, T., Sivam, V., Zhao, T., Frey, O., van der Wal, PD., de Rooij, NF., Dalley, JW. and Edgley, SA., 2011. Multiple extra-synaptic spillover mechanisms regulate prolonged activity in cerebellar Golgi cell-granule cell loops. J Physiol, v. 589
    Doi: http://doi.org/10.1113/jphysiol.2011.207167
  • Theses / dissertations

    2020 (No publication date)

  • Zhao, TX., 2020 (No publication date). PHARMACOLOGICAL MODULATION OF THE ADAPTIVE IMMUNE SYSTEM IN ISCHAEMIC HEART DISEASE
    Doi: 10.17863/CAM.55391
  • Conference proceedings

    2020

  • Zhao, TX., Sriranjan, RS., Lu, Y., Hubsch, A., Kaloyirou, F., Vamvaka, E., Helmy, J., Kostapanos, M., Klatzmann, D., Tedgui, A., Rudd, JHF., Hooles, SP., Bond, SP., Maga, Z. and Cheriyan, J., 2020. Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS) EUROPEAN HEART JOURNAL, v. 41
  • 2018

  • Hoole, SP., Clarke, S., Giblett, J., Aetesam-ur-Rahman, M., Zhao, T., West, N. and Cheriyan, J., 2018. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) HAS NO EFFECT ON PERIPHERAL VASODILATATION BUT AUGMENTS CORONARY MICROCIRCULATORY FLOW IN HUMANS JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, v. 71
    Doi: http://doi.org/10.1016/S0735-1097(18)30561-8
  • Basatemur, G., Ackers-Johnson, M., Schoonejans, J., Kazachenka, A., Lam, B., Ma, M., Brimpari, M., Patel, M., Saleh, N., Murphy, D., Zhao, T., Yeo, G., Ferguson-Smith, A., Vallier, L., Sinha, S. and Mallat, Z., 2018. THE CHR9P21 RISK LOCUS AFFECTS IL-1/TLR SIGNALLING IN VSMC HEART, v. 104
    Doi: http://doi.org/10.1136/heartjnl-2018-BCS.128
  • Aetesam-ur-Rahman, M., Zhao, T., Giblett, J., Braganza, D., Clarke, S., Bennett, M., West, N. and Hoole, S., 2018. Instability of Coronary Flow Velocity and Basal Microvascular Resistance does not Affect Reproducibility of iFR Post- PCI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, v. 72
    Doi: http://doi.org/10.1016/j.jacc.2018.08.1634






  • Cambridge Cardiovascular logo - transparent

    We connect cardiovascular researchers in Cambridge and beyond.

    For inquiries about our research, please contact Dr Jane Sugars

    For enquiries about our website or joining Cambridge Cardiovascular, please contact Denise Hatherly

    Find us on LinkedIn

     

    Follow us on X

    Please follow us here on X for local news about research, events, funding calls, and open positions.

    You must be logged into X to see our feed here:

    Our Newsletter

    Click on the image below for previous Newsletters and for our Email sign up form

     

    Find us on YouTube